Filter
99
Text search:
Lopinavir/Ritonavir
Featured
Recommendations
25
New Publications
27
Language
Document type
No document type
46
Guidelines
33
Fact sheets
9
Studies & Reports
7
Manuals
2
Training Material
1
Infographics
1
Countries / Regions
Ethiopia
3
India
3
Germany
3
Malawi
3
Russia
3
Burkina Faso
2
Nigeria
2
Ghana
2
Uganda
2
Nepal
2
Tanzania
2
Namibia
2
Madagascar
2
East and Southern Africa
2
West and Central Africa
2
Middle East and North Africa
2
Paraguay
2
France
2
Spain
2
Sierra Leone
1
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Niger
1
Togo
1
Haiti
1
Zambia
1
Turkey
1
Kenya
1
Thailand
1
Rwanda
1
South Africa
1
Mozambique
1
Benin
1
Central African Republic
1
Peru
1
Burundi
1
Ecuador
1
Angola
1
Myanmar / Burma
1
Latin America and the Carribbean
1
Luxembourg
1
Venezuela
1
Djibouti
1
Congo-Brazzaville
1
Canada
1
Global
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
49
Clinical Guidelines
8
Pharmacy & Technologies
3
Women & Child Health
2
Key Resources
1
Toolboxes
COVID-19
28
HIV
22
Pharmacy
12
TB
3
Ebola & Marburg
1
Mental Health
1
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi
...
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
This 2015 edition not only updates important changes published in the MEC fifth edition, but also includes several user-friendly features and additional supplemental information, in response to requests WHO has received from stakeholders and partners.
This document highlights the latest WHO recommendations designed to optimize health outcomes, streamline delivery and address persistent barriers to prevention and care. It especially focuses on people often left behind in service delivery, including adolescents and young people, key populations and
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Guía práctica de utilización destinado a médicos, farmacéuticos, enfermeros y auxiliares sanitario.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
El presente documento técnico tiene la finalidad de guiar el manejode cuidados intensivosde los pacientes conCOVID-19 con undoble objetivo: lograr el mejor tratamiento del paciente que contribuya a subuena evolución clínica; ygarantizar los niveles adecuados de prevención y control de la
...
Milestones in the treatment, care and support, Dec 2021
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,
...
Cette pandémie est un défi commun pour l’ensemble de l’humanité dans l’ère de la mondialisation. À ce jour, le partage des ressources, des expériences et des leçons, qui que vous soyez, est notre seule chance de gagner. Le vrai remède à cette pandémie n’est pas l’isolement, mais
...
Guide pratique d’utilisation à l'usage des médecins, pharmaciens, infirmiers et auxiliaires de santé.
